FDA notifications. FDA: tentative approval of generic nevirapine.
D017277:Drug Approval; D016568:Drugs, Generic; D006801:Humans; D019829:Nevirapine; D018894:Reverse Transcriptase Inhibitors; D014481:United States; D014486:United States Food and Drug Administration
D016568:Drugs, Generic; D018894:Reverse Transcriptase Inhibitors; D019829:Nevirapine